ZNTL peer analysis
Zentalis (ZNTL) against its competitors: price, today's move, 1-year return and market value side by side.
- ZNTL's peers: ALXO (ALX Oncology), ARTV (Artiva Biotherapeutics), DTIL (Precision BioSciences), IMMX (Immix Biopharma), MGNX (MacroGenics), PLRX (Pliant Therapeutics), STRO (Sutro Biopharma), STTK (Shattuck Labs).
ZNTL and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALXO ALX Oncology | $1.06 | 3.92% | -27.89% | $137.03M |
| ARTV Artiva Biotherapeutics | $3.82 | -0.26% | 12.68% | $188.83M |
| DTIL Precision BioSciences | $7.40 | 7.09% | 53.53% | $206.72M |
| IMMX Immix Biopharma | $6.96 | -1.14% | 64.54% | $583.33M |
| MGNX MacroGenics | $1.98 | -0.01% | 39.43% | $126.53M |
| PLRX Pliant Therapeutics | $0.62 | -6.20% | -58.67% | $38.43M |
| STRO Sutro Biopharma | $8.60 | -1.38% | -5.49% | $142.77M |
| STTK Shattuck Labs | $4.47 | -1.76% | 128.06% | $455.24M |
| TIL Instil Bio | $5.55 | 2.21% | -54.51% | $37.64M |
| WHWK Whitehawk Therapeutics | $3.12 | -0.32% | 49.28% | $184.11M |
| ZNTL Zentalis | $1.38 | 1.47% | 3.76% | $135.61M |